Bora Pharmaceuticals Co., LTD. (TPE: 6472)

Market Cap	77.38B
Revenue (ttm)	14.17B
Net Income (ttm)	3.19B
Shares Out	100.75M
EPS (ttm)	30.55
PE Ratio	25.14
Forward PE	17.68
Dividend	12.00 (1.57%)
Ex-Dividend Date	Aug 12, 2024

Volume	2,976,849
Open	741.00
Previous Close	727.00
Day's Range	737.00 - 785.00
52-Week Range	612.00 - 975.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Bora Pharmaceuticals Co., LTD.

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2023, Bora Pharmaceuticals Co., LTD.'s revenue was 14.20 billion, an increase of 35.31% compared to the previous year's 10.49 billion. Earnings were 3.03 billion, an increase of 117.70%.